InVitro International, Inc. (IVRO)

OTCMKTS · Delayed Price · Currency is USD
0.0822
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST
-3.24%
Market Cap 1.83M
Revenue (ttm) 811.29K
Net Income (ttm) 106.70K
Shares Out 22.26M
EPS (ttm) 0.00
PE Ratio 20.56
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 43,126
Open 0.0822
Previous Close 0.0822
Day's Range 0.0822 - 0.0822
52-Week Range 0.0550 - 0.1600
Beta -0.72
RSI 42.47
Earnings Date Mar 25, 2026

About InVitro International

InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System install... [Read more]

Sector Healthcare
Founded 1985
Employees 16
Stock Exchange OTCMKTS
Ticker Symbol IVRO
Full Company Profile

Financial Performance

In fiscal year 2024, InVitro International's revenue was $811,290, an increase of 2.35% compared to the previous year's $792,628. Earnings were $106,704, an increase of 6770.83%.

Financial Statements

News

There is no news available yet.